Cite
Prostate cancer cells home to bone using a novel in vivo model: modulation by the integrin antagonist GLPG0187.
MLA
Reeves, Kimberley J., et al. “Prostate Cancer Cells Home to Bone Using a Novel in Vivo Model: Modulation by the Integrin Antagonist GLPG0187.” International Journal of Cancer, vol. 136, no. 7, Apr. 2015, pp. 1731–40. EBSCOhost, https://doi.org/10.1002/ijc.29165.
APA
Reeves, K. J., Hurrell, J. E., Cecchini, M., van der Pluijm, G., Down, J. M., Eaton, C. L., Hamdy, F., Clement-Lacroix, P., & Brown, N. J. (2015). Prostate cancer cells home to bone using a novel in vivo model: modulation by the integrin antagonist GLPG0187. International Journal of Cancer, 136(7), 1731–1740. https://doi.org/10.1002/ijc.29165
Chicago
Reeves, Kimberley J, Jack E Hurrell, Marco Cecchini, Gabri van der Pluijm, Jenny M Down, Colby L Eaton, Freddie Hamdy, Philippe Clement-Lacroix, and Nicola J Brown. 2015. “Prostate Cancer Cells Home to Bone Using a Novel in Vivo Model: Modulation by the Integrin Antagonist GLPG0187.” International Journal of Cancer 136 (7): 1731–40. doi:10.1002/ijc.29165.